Senseye: Integrating Senseye's Breakthrough Solution in Telehealth for Mental Health Diagnostics

Senseye Inc. proposes to integrate its breakthrough AI-powered digital biomarker platform into the Air Force's telehealth systems to address the urgent need for rapid, objective mental health diagnostics. Senseye’s solution leverages smartphone cameras to capture and analyze ocular data, providing accurate and non-invasive assessments of conditions such as PTSD, depression, and anxiety. The platform delivers real-time results without requiring internet connectivity, making it ideal for low-bandwidth and remote environments. This enables on-demand mental health evaluations in less than 15 minutes, significantly improving diagnostic speed, precision, and accessibility for service members, regardless of their location.The proposed Phase I effort aims to demonstrate the technical feasibility of deploying Senseye’s mobile-enabled application within the Department of Defense's (DoD) telehealth ecosystem. Through a series of trials, Senseye’s platform will undergo adaptation to meet the unique requirements of military settings. The ultimate goal is to enhance operational readiness by enabling commanders and clinicians to monitor the mental health status of personnel, providing timely interventions before issues escalate into critical conditions.Senseye's platform, validated through clinical trials and ongoing SBIR-funded work, addresses the growing demand for objective mental health diagnostics in both military and civilian healthcare systems. With over $13.8M in funding and a strong track record of peer-reviewed research, Senseye is poised to revolutionize mental health diagnostics through its scalable and cost-effective solution, while advancing toward FDA approval. This innovation will support the Air Force’s telehealth initiatives, reduce stigma, improve mission readiness, and ensure mental health interventions are accessible to all personnel, even in the most austere environments.